Participated · Series B · Jan 2022

Remilk is a Tel Aviv–based food startup that produces dairy-identical milk proteins through a fermentation process. The company has developed a patented approach to scalable manufacturing that it says increases production efficiency and removes the need for dairy cows at industrial scale without compromising taste, functionality, or nutritional values. Remilk intends to scale production for commercial use by manufacturers of traditionally dairy-based products, including cheeses, yogurt, and ice cream. The company is positioned as a global leader in the development of animal-free dairy. Remilk was co-founded by Aviv Wolff, an entrepreneur with experience at several startups, and Ori Cohavi, PhD in biochemistry, who has worked in R&D at various biotech firms. The article reports a significant Series B financing that will support the company’s production scale-up plans. Remilk develops animal-free dairy by producing identical dairy proteins via a proprietary, patented microbial fermentation process. Its lab-made dairy proteins are designed to be functionally and sensorially identical to natural dairy and are used as starting materials by commercial manufacturers for cheese, yogurt and cream production. The company says its products are cholesterol-free and contain no lactose, antibiotics or growth hormones. Remilk highlights sustainability advantages, claiming its process requires 1% of the land, 4% of the feedstock and 10% of the water compared with traditional dairy. With new production and distribution partnerships, Remilk plans rapid expansion to meet global demand and to enable industrial-scale, cow-free dairy protein production.